Magazine Article | December 24, 2014

From Publish-Or-Perish To Product Creation – Putting Your Research Into Action

Source: Life Science Leader

Neoantigenics is a biotechnology company that was based on unique IP that was discovered at the University of Virginia (UVA). John Herr, Ph.D., chief scientific officer, is the principal investigator and a tenured professor in the Departments of Cell Biology and Biomedical Engineering at UVA.